Skip to main content
. Author manuscript; available in PMC: 2011 Nov 16.
Published in final edited form as: Biochemistry. 2010 Oct 25;49(45):9866–9873. doi: 10.1021/bi101412m

Figure. 4.

Figure. 4

[3H]CE uptake from HDL ± rSOF treatment by CHO cell variants. Left panels, CHO-K1; middle panels, CHO-ldlA7; right panels, CHO-SR-BI. A – C: time course; D – F: dose response; (○) HDL-[3H]CE; (●) HDL-[3H]CE pretreated with rSOF to form CERM-[3H]CE. G –L: Inhibition of CHO cell [3H]CE Uptake from HDL ± rSOF treatment by unlabeled lipoproteins. CHO cell variants were incubated with 10 μg/mL HDL-[3H]CE ± rSOF pretreatment in the presence or absence of a 10- or 20-fold excess (100 or 200 μg/mL) human plasma HDL or LDL. *p < 0.05, +rSOF vs. control. Numbers above bars are the ratio of (%CERM-CE uptake/%HDL-CE uptake) in the presence of the various lipoprotein inhibitors.